Blood Plasma Derivatives Global Market Opportunities And Strategies To 2033

Description

Blood plasma derivatives are medical products derived from human blood plasma. Plasma is the liquid component of blood that remains after cells (red blood cells, white blood cells and platelets) are removed. Plasma derivatives are typically obtained through a process called fractionation, where plasma proteins are separated and purified from the collected plasma.

The blood plasma derivatives market consists of sales, by entities (organizations, sole traders and partnerships), of products derived from the plasma portion of human blood.

The global blood plasma derivatives market was valued at $31,712.7 million in 2018 which grew till 2023 at a compound annual growth rate (CAGR) of more than 8.0%.

Rise In Hemophilia Prevalence

The rise in hemophilia prevalence drove the growth of the blood plasma derivatives market during this historic period. Hemophilia is a genetic disorder characterized by the inability of the blood to clot properly. This condition is typically inherited and primarily affects males. Blood plasma derivatives play a crucial role in the management of hemophilia by providing the necessary clotting factors to restore hemostasis and prevent or treat bleeding episodes effectively. While recombinant clotting factor products offer enhanced safety profiles and supply stability, plasma-derived factors remain crucial, especially in regions with limited access to recombinant products or for patients with inhibitors against them. Despite concerns regarding blood-borne pathogen transmission, plasma-derived products continue to provide a cost-effective and accessible option for treating hemophilia, ensuring the effective management of bleeding episodes and restoration of hemostasis. In August 2022, according to the Centers for Disease Control and Prevention (CDC), a US-based national public health agency, for every 100,000 American males, there were 3.7 instances of hemophilia B and 12 cases of hemophilia A, respectively. Moreover, it affects 1 in 5,617 male births in the US and 1 in 19,283 male births with hemophilia B. Therefore, the rise in hemophilia prevalence drove the blood plasma derivatives market.

Increasing Investments To Expand Blood Plasma Production Capabilities

Companies in the blood plasma derivatives market are focusing on increasing their investments to capitalize on growth opportunities and contribute to long-term sustainability and profitability. For example, in September 2022, Takeda Pharmaceutical Company Limited, a Japan-based pharmaceutical company, invested close to $330 million in expanding its plasma-derived therapy production. This investment aims to enhance access to treatments for rare and complex chronic diseases, such as primary immunodeficiencies and rare conditions like hereditary angioedema and bleeding disorders. Furthermore, in March 2023, CSL Plasma, a US-based plasmapheresis company, invested $470 million to establish a new plasma fractionation facility at its site located in Marburg to expand its production capabilities and enhance its commitment to delivering on its promise to patients.

The global blood plasma derivatives market is fairly concentrated, with a large number of players operating in the market. The top ten competitors in the market made up to 22.6% of the total market in 2022.

Blood Plasma Derivatives Global Market Opportunities And Strategies To 2033 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global blood plasma derivatives market as it emerges from the COVID-19 shut down.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market research findings.
Benchmark performance against key competitors.
Utilize the relationships between key data sets for superior strategizing.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis.

Where is the largest and fastest-growing market for blood plasma derivatives? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The blood plasma derivatives market global report from The Business Research Company answers all these questions and many more.

The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market's history and forecasts market growth by geography. It places the market within the context of the wider blood plasma derivatives market; and compares it with other markets.

The report covers the following chapters

Introduction and Market Characteristics- Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by type, by application and by end-user.
Key Trends- Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
Macro-Economic Scenario- The report provides an analysis of the impact of the COVID-19 pandemic, impact of the Russia-Ukraine war and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the blood plasma derivatives market.
Global Market Size And Growth- Global historic (2018-2023) and forecast (2023-2028, 2033F) market values and drivers and restraints that support and control the growth of the market in the historic and forecast periods.
Regional And Country Analysis- Historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison by region and country.
Market Segmentation- Contains the market values (2018-2023) (2023-2028, 2033F) and analysis for each segment by type, by application and by end-user in the market. Historic (2018-2023) and forecast (2023-2028) and (2028-2033) market values and growth and market share comparison by region market.
Regional Market Size and Growth- Regional market size (2023), historic (2018-2023) and forecast (2023-2028, 2033F) market values and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
Competitive Landscape- Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
Other Major And Innovative Companies- Details on the company profiles of other major and innovative companies in the market.
Competitive Benchmarking- Briefs on the financials comparison between major players in the market.
Competitive Dashboard- Briefs on competitive dashboard of major players.
Key Mergers And Acquisitions- Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
Market Opportunities And Strategies- Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
Conclusions And Recommendations-This section includes recommendations for blood plasma derivatives providers in terms of product/service offerings geographic expansion, marketing strategies and target groups next five years.
Appendix- This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Markets Covered:

1) By Type: Albumin; Factor VIII; Factor IX; Immunoglobulin; Hyperimmune Globulin; Other Types
2) By Application: Haemophilia; Hypogammaglobulinemia; Immunodeficiency Diseases; Von Willebrand's Disease; Other Application
3) By End-User: Hospitals; Clinics; Other End-Users
Companies Mentioned: CSL Limited; China Biologic Products Holdings Inc.; Takeda Pharmaceutical Company Limited; Octapharma AG; Bayer AG
Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Canada; Brazil; France; Germany; Italy; Spain; UK; Russia
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time-series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; blood plasma derivatives indicators comparison.
Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Product Code: o&s1190

1 Executive Summary

1.1 Blood Plasma Derivatives - Market Attractiveness And Macro economic Landscape

2 Table Of Contents

3 List Of Tables

4 List Of Figures

5 Report Structure

6 Market Characteristics

6.1 General Market Definition
6.2 Summary
6.3 Blood Plasma Derivatives Market Definition And Segmentations
6.4 Market Segmentation By Type
- 6.4.1 Albumin
- 6.4.2 Factor VIII
- 6.4.3 Factor IX
- 6.4.4 Immunoglobulin
- 6.4.5 Hyperimmune Globulin
- 6.4.6 Other Types
6.5 Market Segmentation By Application
- 6.5.1 Hemophilia
- 6.5.2 Hypogammaglobulinemia
- 6.5.3 Immunodeficiency Diseases
- 6.5.4 Von Willebrand's Disease
- 6.5.5 Other Applications
6.6 Market Segmentation By End-User
- 6.6.1 Hospitals
- 6.6.2 Clinics
- 6.6.3 Other End-Users

7 Major Market Trends

7.1 New Blood Plasma Manufacturing Facilities To Enhance Supply Chain Resilience
7.2 Increasing Investments To Expand Blood Plasma Production Capabilities
7.3 Innovative Formulations To Address Hepatitis B Virus Exposure
7.4 Strategic Partnerships And Collaborations To Strengthen Blood Plasma Derivatives Development

8 Blood Plasma Derivatives Market - Macro Economic Scenario

8.1 COVID-19 Impact On The Blood Plasma Derivatives Market
8.2 Impact Of The War In Ukraine On The Blood Plasma Derivatives Market
8.3 Impact Of High Inflation On The Blood Plasma Derivatives Market

9 Global Market Size and Growth

9.1 Market Size
9.2 Historic Market Growth, 2018 - 2023, Value ($ Million)
- 9.2.1 Market Drivers 2018 - 2023
- 9.2.2 Market Restraints 2018 - 2023
9.3 Forecast Market Growth, 2023 - 2028, 2033F Value ($ Million)
- 9.3.1 Market Drivers 2023 - 2028
- 9.3.2 Market Restraints 2023 - 2028

10 Global Blood Plasma Derivatives Market Segmentation

10.1 Global Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.2 Global Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
10.3 Global Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

11 Blood Plasma Derivatives Market, Regional and Country Analysis

11.1 Global Blood Plasma Derivatives Market, By Region, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
11.2 Global Blood Plasma Derivatives Market, By Country, Historic and Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

12 Asia-Pacific Market

12.1 Summary
- 12.1.1 Market Overview
- 12.1.2 Region Information
- 12.1.3 Market Information
- 12.1.4 Background Information
- 12.1.5 Government Initiatives
- 12.1.6 Regulations
- 12.1.7 Regulatory Bodies
- 12.1.8 Major Associations
- 12.1.9 Taxes Levied
- 12.1.10 Corporate Tax Structure
- 12.1.11 Investments
- 12.1.12 Major Companies
12.2 Asia-Pacific Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.3 Asia-Pacific Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.4 Asia-Pacific Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.5 Asia-Pacific Blood Plasma Derivatives Market: Country Analysis
12.6 China Market
12.7 Summary
- 12.7.1 Market Overview
- 12.7.2 Country Information
- 12.7.3 Market Information
- 12.7.4 Background Information
- 12.7.5 Government Initiatives
- 12.7.6 Regulations
- 12.7.7 Regulatory Bodies
- 12.7.8 Major Associations
- 12.7.9 Taxes Levied
- 12.7.10 Corporate Tax Structure
- 12.7.11 Investments
- 12.7.12 Major Companies
12.8 China Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.9 China Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.10 China Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.11 India Market
12.12 India Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.13 India Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.14 India Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.15 Japan Market
12.16 Japan Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.17 Japan Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.18 Japan Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.19 Australia Market
12.20 Australia Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.21 Australia Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.22 Australia Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.23 Indonesia Market
12.24 Indonesia Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.25 Indonesia Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.26 Indonesia Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.27 South Korea Market
12.28 South Korea Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.29 South Korea Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
12.30 South Korea Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

13 Western Europe Market

13.1 Summary
- 13.1.1 Market Overview
- 13.1.2 Region Information
- 13.1.3 Market Information
- 13.1.4 Background Information
- 13.1.5 Government Initiatives
- 13.1.6 Regulations
- 13.1.7 Regulatory Bodies
- 13.1.8 Major Associations
- 13.1.9 Taxes Levied
- 13.1.10 Corporate Tax Structure
- 13.1.11 Investments
- 13.1.12 Major Companies
13.2 Western Europe Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.3 Western Europe Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.4 Western Europe Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.5 Western Europe Blood Plasma Derivatives Market: Country Analysis
13.6 UK Market
13.7 UK Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.8 UK Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.9 UK Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.10 Germany Market
13.11 Germany Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.12 Germany Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.13 Germany Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.14 France Market
13.15 France Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.16 France Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.17 France Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.18 Italy Market
13.19 Italy Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.20 Italy Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.21 Italy Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.22 Spain Market
13.23 Spain Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.24 Spain Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
13.25 Spain Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

14 Eastern Europe Market

14.1 Summary
- 14.1.1 Market Overview
- 14.1.2 Region Information
- 14.1.3 Market Information
- 14.1.4 Background Information
- 14.1.5 Government Initiatives
- 14.1.6 Regulations
- 14.1.7 Regulatory Bodies
- 14.1.8 Major Associations
- 14.1.9 Taxes Levied
- 14.1.10 Corporate Tax Structure
- 14.1.11 Investments
- 14.1.12 Major Companies
14.2 Eastern Europe Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.3 Eastern Europe Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.4 Eastern Europe Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.5 Eastern Europe Blood Plasma Derivatives Market: Country Analysis
14.6 Russia Market
14.7 Russia Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.8 Russia Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
14.9 Russia Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

15 North America Market

15.1 Summary
- 15.1.1 Market Overview
- 15.1.2 Region Information
- 15.1.3 Market Information
- 15.1.4 Background Information
- 15.1.5 Government Initiatives
- 15.1.6 Regulations
- 15.1.7 Regulatory Bodies
- 15.1.8 Major Associations
- 15.1.9 Taxes Levied
- 15.1.10 Corporate Tax Structure
- 15.1.11 Investments
- 15.1.12 Major Companies
15.2 North America Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.3 North America Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.4 North America Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.5 North America Blood Plasma Derivatives Market: Country Analysis
15.6 USA Market
15.7 Summary
- 15.7.1 Market Overview
- 15.7.2 Country Information
- 15.7.3 Market Information
- 15.7.4 Background Information
- 15.7.5 Government Initiatives
- 15.7.6 Regulations
- 15.7.7 Regulatory Bodies
- 15.7.8 Major Associations
- 15.7.9 Taxes Levied
- 15.7.10 Corporate Tax Structure
- 15.7.11 Investments
- 15.7.12 Major Companies
15.8 USA Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.9 USA Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.10 USA Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.11 Canada Market
15.12 Canada Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.13 Canada Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
15.14 Canada Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

16 South America Market

16.1 Summary
- 16.1.1 Market Overview
- 16.1.2 Region Information
- 16.1.3 Market Information
- 16.1.4 Background Information
- 16.1.5 Government Initiatives
- 16.1.6 Regulations
- 16.1.7 Regulatory Bodies
- 16.1.8 Major Associations
- 16.1.9 Taxes Levied
- 16.1.10 Corporate Tax Structure
- 16.1.11 Major Companies
16.2 South America Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.3 South America Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.4 South America Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.5 South America Blood Plasma Derivatives Market: Country Analysis
16.6 Brazil Market
16.7 Brazil Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.8 Brazil Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
16.9 Brazil Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

17 Middle East Market

17.1 Summary
- 17.1.1 Market Overview
- 17.1.2 Region Information
- 17.1.3 Market Information
- 17.1.4 Background Information
- 17.1.5 Government Initiatives
- 17.1.6 Regulations
- 17.1.7 Regulatory Bodies
- 17.1.8 Major Associations
- 17.1.9 Taxes Levied
- 17.1.10 Corporate Tax Structure
- 17.1.11 Investments
- 17.1.12 Major Companies
17.2 Middle East Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17.3 Middle East Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
17.4 Middle East Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

18 Africa Market

18.1 Summary
- 18.1.1 Market Overview
- 18.1.2 Region Information
- 18.1.3 Market Information
- 18.1.4 Background Information
- 18.1.5 Government Initiatives
- 18.1.6 Regulations
- 18.1.7 Regulatory Bodies
- 18.1.8 Major Associations
- 18.1.9 Taxes Levied
- 18.1.10 Corporate Tax Structure
- 18.1.11 Investments
- 18.1.12 Major Companies
18.2 Africa Blood Plasma Derivatives Market, Segmentation By Type, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
18.3 Africa Blood Plasma Derivatives Market, Segmentation By Application, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)
18.4 Africa Blood Plasma Derivatives Market, Segmentation By End-User, Historic And Forecast, 2018 - 2023, 2028F, 2033F, Value ($ Million)

19 Competitive Landscape And Company Profiles

19.1 Company Profiles
19.2 CSL Limited
- 19.2.1 Company Overview
- 19.2.2 Products And Services
- 19.2.3 Business Strategy
- 19.2.4 Financial Overview
19.3 China Biologic Products Holdings Inc.
- 19.3.1 Company Overview
- 19.3.2 Products And Services
- 19.3.3 Financial Overview
19.4 Takeda Pharmaceutical Company Limited
- 19.4.1 Company Overview
- 19.4.2 Products And Services
- 19.4.3 Business Strategy
- 19.4.4 Financial Performance
19.5 Octapharma AG
- 19.5.1 Company Overview
- 19.5.2 Products And Services
- 19.5.3 Business Strategy
- 19.5.4 Financial Overview
19.6 Bayer AG
- 19.6.1 Company Overview
- 19.6.2 Products And Services
- 19.6.3 Financial Performance

20 Blood Plasma Derivatives Market Other Major And Innovative Companies

20.1 Kedrion S.p.A.
- 20.1.1 Company Overview
- 20.1.2 Products And Services
20.2 Bio Products Ltd.
- 20.2.1 Company Overview
- 20.2.2 Products And Services
20.3 Grifols S.A.
- 20.3.1 Company Overview
- 20.3.2 Products And Services
20.4 LFB S.A.
- 20.4.1 Company Overview
- 20.4.2 Products And Services
20.5 ADMA Biologics Inc.
- 20.5.1 Company Overview
- 20.5.2 Products And Services
20.6 GC Biopharma Corp.
- 20.6.1 Company Overview
- 20.6.2 Products And Services
20.7 Shanghai Raas Blood Products Co. Ltd.
- 20.7.1 Company Overview
- 20.7.2 Products And Services
20.8 Emergent BioSolutions Inc.
- 20.8.1 Company Overview
- 20.8.2 Products And Services
20.9 Biotest AG
- 20.9.1 Company Overview
- 20.9.2 Products And Services
20.10 SK Plasma Co., Ltd.
- 20.10.1 Company Overview
- 20.10.2 Products And Services
20.11 BioreclamationIVT
- 20.11.1 Company Overview
- 20.11.2 Products And Services
20.12 Fusion Health Care Pvt. Ltd.
- 20.12.1 Company Overview
- 20.12.2 Products And Services
20.13 PlasmaGen BioSciences Private Limited
- 20.13.1 Company Overview
- 20.13.2 Products And Services
20.14 Cambryn Biologics LLC
- 20.14.1 Company Overview
- 20.14.2 Products And Services
20.15 Sanquin Innovation B.V.
- 20.15.1 Company Overview
- 20.15.2 Products And Services

21 Competitive Benchmarking

22 Competitive Dashboard

23 Key Mergers And Acquisitions

23.1 Pfizer Inc. Acquired Blood Therapeutics Inc.
23.2 Grifols S.A. Acquired Biotest AG
23.3 Grifols S.A. Acquired 25 Plasma Centers From BPL Plasma Inc.
23.4 Permira Acquired Kedrion Biopharma
23.5 Kamada Ltd. Acquired FDA-Licensed Plasma Collection Center From Blood and Plasma Research Inc.

24 Opportunities And Strategies

24.1 Global Blood Plasma Derivatives Market In 2028 - Countries Offering Most New Opportunities
24.2 Global Blood Plasma Derivatives Market In 2028 - Segments Offering Most New Opportunities
24.3 Global Blood Plasma Derivatives Market In 2028 - Growth Strategies
- 24.3.1 Market Trend Based Strategies
- 24.3.2 Competitor Strategies

25 Blood Plasma Derivatives Market, Conclusions And Recommendations

25.1 Conclusions
25.2 Recommendations
- 25.2.1 Product
- 25.2.2 Place
- 25.2.3 Price
- 25.2.4 Promotion
- 25.2.5 People

26 Appendix

26.1 Geographies Covered
26.2 Market Data Sources
26.3 Research Methodology
26.4 Currencies
26.5 The Business Research Company
26.6 Copyright and Disclaimer